About 5-bromo-3-[1-[2-[5-[[1-(cyclopropylmethyl)-3-methylpyrazol-4-yl]methyl]-3-methylpyrazol-1-yl]-5-fluorophenyl]ethoxy]-2-nitropyridine
5-bromo-3-[1-[2-[5-[[1-(cyclopropylmethyl)-3-methylpyrazol-4-yl]methyl]-3-methylpyrazol-1-yl]-5-fluorophenyl]ethoxy]-2-nitropyridine (PubChem CID 164718522) has the molecular formula C26H26BrFN6O3
and a molecular weight of 569.44 g/mol. Its IUPAC name is 5-bromo-3-[1-[2-[5-[[1-(cyclopropylmethyl)-3-methylpyrazol-4-yl]methyl]-3-methylpyrazol-1-yl]-5-fluorophenyl]ethoxy]-2-nitropyridine.
Molecular Properties
| Compound Name | 5-bromo-3-[1-[2-[5-[[1-(cyclopropylmethyl)-3-methylpyrazol-4-yl]methyl]-3-methylpyrazol-1-yl]-5-fluorophenyl]ethoxy]-2-nitropyridine |
| PubChem CID | 164718522 |
| Molecular Formula | C26H26BrFN6O3 |
| Molecular Weight | 569.44 g/mol |
| Exact Mass | 568.12 |
| IUPAC Name | 5-bromo-3-[1-[2-[5-[[1-(cyclopropylmethyl)-3-methylpyrazol-4-yl]methyl]-3-methylpyrazol-1-yl]-5-fluorophenyl]ethoxy]-2-nitropyridine |
| SMILES | Cc1cc(Cc2cn(CC3CC3)nc2C)n(-c2ccc(F)cc2C(C)Oc2cc(Br)cnc2[N+](=O)[O-])n1 |
| InChI | InChI=1S/C26H26BrFN6O3/c1-15-8-22(9-19-14-32(31-16(19)2)13-18-4-5-18)33(30-15)24-7-6-21(28)11-23(24)17(3)37-25-10-20(27)12-29-26(25)34(35)36/h6-8,10-12,14,17-18H,4-5,9,13H2,1-3H3 |
| InChIKey | IHCMZRMAWXTZAE-UHFFFAOYSA-N |
| XLogP | 6.03 |
| TPSA | 100.90 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
| MW ≤ 500 | 569.44 |
| LogP ≤ 5 | 6.03 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 8 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'nitro_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'} |
|---|
Analyze 5-bromo-3-[1-[2-[5-[[1-(cyclopropylmethyl)-3-methylpyrazol-4-yl]methyl]-3-methylpyrazol-1-yl]-5-fluorophenyl]ethoxy]-2-nitropyridine with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 5-bromo-3-[1-[2-[5-[[1-(cyclopropylmethyl)-3-methylpyrazol-4-yl]methyl]-3-methylpyrazol-1-yl]-5-fluorophenyl]ethoxy]-2-nitropyridine?
The IUPAC name of 5-bromo-3-[1-[2-[5-[[1-(cyclopropylmethyl)-3-methylpyrazol-4-yl]methyl]-3-methylpyrazol-1-yl]-5-fluorophenyl]ethoxy]-2-nitropyridine (CID 164718522) is 5-bromo-3-[1-[2-[5-[[1-(cyclopropylmethyl)-3-methylpyrazol-4-yl]methyl]-3-methylpyrazol-1-yl]-5-fluorophenyl]ethoxy]-2-nitropyridine.
What is the SMILES notation for 5-bromo-3-[1-[2-[5-[[1-(cyclopropylmethyl)-3-methylpyrazol-4-yl]methyl]-3-methylpyrazol-1-yl]-5-fluorophenyl]ethoxy]-2-nitropyridine?
The canonical SMILES for 5-bromo-3-[1-[2-[5-[[1-(cyclopropylmethyl)-3-methylpyrazol-4-yl]methyl]-3-methylpyrazol-1-yl]-5-fluorophenyl]ethoxy]-2-nitropyridine is Cc1cc(Cc2cn(CC3CC3)nc2C)n(-c2ccc(F)cc2C(C)Oc2cc(Br)cnc2[N+](=O)[O-])n1.
What is the InChIKey of 5-bromo-3-[1-[2-[5-[[1-(cyclopropylmethyl)-3-methylpyrazol-4-yl]methyl]-3-methylpyrazol-1-yl]-5-fluorophenyl]ethoxy]-2-nitropyridine?
The InChIKey is IHCMZRMAWXTZAE-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H26BrFN6O3/c1-15-8-22(9-19-14-32(31-16(19)2)13-18-4-5-18)33(30-15)24-7-6-21(28)11-23(24)17(3)37-25-10-20(27)12-29-26(25)34(35)36/h6-8,10-12,14,17-18H,4-5,9,13H2,1-3H3.
What are the key properties of 5-bromo-3-[1-[2-[5-[[1-(cyclopropylmethyl)-3-methylpyrazol-4-yl]methyl]-3-methylpyrazol-1-yl]-5-fluorophenyl]ethoxy]-2-nitropyridine?
5-bromo-3-[1-[2-[5-[[1-(cyclopropylmethyl)-3-methylpyrazol-4-yl]methyl]-3-methylpyrazol-1-yl]-5-fluorophenyl]ethoxy]-2-nitropyridine has a molecular weight of 569.44 g/mol, XLogP of 6.03, 9 rotatable bonds, 0 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 5-bromo-3-[1-[2-[5-[[1-(cyclopropylmethyl)-3-methylpyrazol-4-yl]methyl]-3-methylpyrazol-1-yl]-5-fluorophenyl]ethoxy]-2-nitropyridine is sourced from PubChem (CID 164718522), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).